Opinions in Healthcare

Kisunla

Kisunla: A New Breakthrough for Alzheimer’s Disease The FDA’s approval of Kisunla (donanemab-azbt) marks a significant advancement in the treatment of early-stage Alzheimer’s disease. Kisunla was developed by Eli Lilly, and this new

Read More

Compounding Pharmacy

What is Compounding? Today, compounding is a practice generally conducted by a licensed pharmacist or outsourcing facility requiring discipline and precision. The core demand for compounding pharmacies is the necessity of a formulation

Read More

Onyda XR

On May 24, 2024, the FDA approved Onyda XR (clonidine hydrochloride), a liquid non-stimulant medication for attention deficit hyperactivity disorder (ADHD). Developed by Tris Pharma, Onyda XR is a centrally acting alpha 2

Read More

Wegovy Shortage

In recent months, there has been a surge in clinicians prescribing subcutaneous injections for weight loss to their patients. As a result, manufacturers have struggled to keep up with the increased demand. Pharmacies

Read More

Opill

On July 13, 2023, the FDA approved the first over-the-counter birth control called ‘Opill’. An increased availability of hormonal birth control without a prescription may increase access and remove the barriers that individuals

Read More